ELEV - Elevation Oncology, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 90.63M
Enterprise value 29.78M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.85
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.34

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3122.12%
S&P500 52-week change 31.77%
52-week high 35.8900
52-week low 30.7230
50-day moving average 32.7172
200-day moving average 31.4997

Share statistics

Avg vol (3-month) 31.97M
Avg vol (10-day) 37.34M
Shares outstanding 524.34M
Implied shares outstanding 6N/A
Float 86.16M
% held by insiders 12.15%
% held by institutions 174.24%
Shares short (14 May 2023) 4369.12k
Short ratio (14 May 2023) 40.4
Short % of float (14 May 2023) 41.90%
Short % of shares outstanding (14 May 2023) 41.52%
Shares short (prior month 13 Apr 2023) 4130.57k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-52.57%
Return on equity (ttm)-120.36%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -88.79M
Net income avi to common (ttm)-94.86M
Diluted EPS (ttm)-6.7900
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)73.93M
Total cash per share (mrq)3.04
Total debt (mrq)29.6M
Total debt/equity (mrq)87.67
Current ratio (mrq)5.60
Book value per share (mrq)1.42

Cash flow statement

Operating cash flow (ttm)-88.29M
Levered free cash flow (ttm)-48.14M